Oriental Fortune Capital
UINO has announced the completion of the Series B+ round of financing. The round was led by China Broadband Capital Partners and Chenshan Capital, with participation Oriental Fortune Capital and Hundsun Technologies.
JS InnoPharm announced the completion of nearly 100 million yuan in its Series A+ round of financing, which was led by Ming Bioventures and participated by Efung Capital, SIDVC, Zhidao Capital and Oriental Fortune Capital.
The leading company in the data security field in China, Meichuang Technology, has recently completed a new round of financing, raising 150 million yuan. This round was led by Shengyu Investment and China Broadband Capital Partners, with participation from Zhejiang Cybernaut Investment, Yuyue Medical and Oriental Fortune Capital.
Innovative drug research and development company Shenzhen TargetRx recently announced that the company has raised 150 million yuan in a Series A financing round.
This round of investment was led by CCB International’s Jianxing Fund, with participation from Oriental Fortune Capital, Tsing-yuan Capital, and existing investor Shenzhen Capital Group and others.